Toward a Theranostic Approach for the Brain Tumor Toxicity Profile of Polymer-Shelled Microbubbles

Overview

Journal ACS Omega

Publisher American Chemical Society

Specialty Chemistry

Date 2025 Feb 17

PMID 39959058

Authors

Gaio Paradossi

Fabio Domenici

Francesco Riccitelli

Rachel Grossman

Affiliations

Soon will be listed here.

Abstract

The establishment of theranostic devices by combining multimodal real-time intraoperative imaging for brain tumor surgery with targeted drug delivery may provide therapeutic advantages for patients with malignant gliomas. Our group has recently developed a new generation of novel microbubbles (MBs), with an air core and a crosslinked poly(vinyl alcohol) shell, called PVA MBs. The PVA MB surface was engineered to support near-infrared (NIR) imaging with a fluorescence probe (C790) for the surgical microscope. The attachment to a cyclic pentapeptide containing the RGD sequence promotes active adhesion and direct targeting of endothelial tumor integrins. The conjugation of temozolomide (TMZ), an alkylating chemotherapy proven to be effective against malignant gliomas, provides a unique therapeutic advantage. The potential toxicity of this novel technology was assessed in rats by intravenous injections of two doses of naked MBs and MBs equipped with RGD for targeting tumor integrins, NIR fluorescence (CF790) for real-time visualization, and TMZ as a cytotoxic component, at two time points, 10 min and 7 days, for potential acute and chronic responses in rats [(1) MB, (2) MB-C790-RGD, and (3) MB-C790-RGD-TMZ]. No mortality occurred during the 7-day study period in any of the dosing groups. Decreased hemoglobin and hematocrit levels and increased triglyceride levels were noticed in the high-dose naked MBs and MBs-CF790-RGD groups. These findings may be associated with their enlarged spleen and liver, observed during necropsy. Histopathology examination in the high-dose animals showed the development of treatment-related changes seen mostly 7 days post dosing, consisting of granulomatous inflammation and foreign body reaction. Accordingly, we concluded that the low-dose tested items appeared to be safe. The results allow us to proceed with planning for an efficacy study before making the first attempt to use this technology in clinical practice.

References

Jamburidze A, Huerre A, Baresch D, Poulichet V, De Corato M, Garbin V . Nanoparticle-Coated Microbubbles for Combined Ultrasound Imaging and Drug Delivery. Langmuir. 2019; 35(31):10087-10096. DOI: 10.1021/acs.langmuir.8b04008. View

Grossman R, Shimony N, Shir D, Gonen T, Sitt R, Jonas Kimchi T . Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival. Ann Surg Oncol. 2016; 24(3):794-800. DOI: 10.1245/s10434-016-5635-z. View

Kothapalli S, Oddo L, Paradossi G, Brodin L, Grishenkov D . Assessment of the viscoelastic and oscillation properties of a nano-engineered multimodality contrast agent. Ultrasound Med Biol. 2014; 40(10):2476-87. DOI: 10.1016/j.ultrasmedbio.2014.05.018. View

Amin M, Mansourian M, Koning G, Badiee A, Jaafari M, Ten Hagen T . Development of a novel cyclic RGD peptide for multiple targeting approaches of liposomes to tumor region. J Control Release. 2015; 220(Pt A):308-315. DOI: 10.1016/j.jconrel.2015.10.039. View

Barrefelt A, Brismar T, Egri G, Aspelin P, Olsson A, Oddo L . Multimodality imaging using SPECT/CT and MRI and ligand functionalized 99mTc-labeled magnetic microbubbles. EJNMMI Res. 2013; 3(1):12. PMC: 3599195. DOI: 10.1186/2191-219X-3-12. View

Kerlin R, Bolon B, Burkhardt J, Francke S, Greaves P, Meador V . Scientific and Regulatory Policy Committee: Recommended ("Best") Practices for Determining, Communicating, and Using Adverse Effect Data from Nonclinical Studies. Toxicol Pathol. 2015; 44(2):147-62. DOI: 10.1177/0192623315623265. View

Schoen Jr S, Kilinc M, Lee H, Guo Y, Degertekin F, Woodworth G . Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound. Adv Drug Deliv Rev. 2021; 180:114043. PMC: 8724442. DOI: 10.1016/j.addr.2021.114043. View

Teraiya M, Perreault H, Chen V . An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?. Front Oncol. 2023; 13:1166207. PMC: 10169742. DOI: 10.3389/fonc.2023.1166207. View

Ferrara K, Pollard R, Borden M . Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng. 2007; 9:415-47. DOI: 10.1146/annurev.bioeng.8.061505.095852. View

10.

Paradossi G, Grossman R, Riccitelli F, Todaro F, Ram Z, Schioppa S . Toward a theranostic device for gliomas. Biochem Biophys Res Commun. 2023; 671:124-131. DOI: 10.1016/j.bbrc.2023.05.089. View

11.

Parchur A, Sharma G, Jagtap J, Gogineni V, LaViolette P, Flister M . Vascular Interventional Radiology-Guided Photothermal Therapy of Colorectal Cancer Liver Metastasis with Theranostic Gold Nanorods. ACS Nano. 2018; 12(7):6597-6611. PMC: 9272590. DOI: 10.1021/acsnano.8b01424. View

12.

Grishenkov D, Kari L, Brodin L, Brismar T, Paradossi G . In vitro contrast-enhanced ultrasound measurements of capillary microcirculation: comparison between polymer- and phospholipid-shelled microbubbles. Ultrasonics. 2010; 51(1):40-8. DOI: 10.1016/j.ultras.2010.05.006. View

13.

Cerroni B, Cicconi R, Oddo L, Scimeca M, Bonfiglio R, Bernardini R . biological fate of poly(vinylalcohol) microbubbles in mice. Heliyon. 2018; 4(9):e00770. PMC: 6143702. DOI: 10.1016/j.heliyon.2018.e00770. View

14.

Guo Y, Lee H, Kim C, Park C, Yamamichi A, Chuntova P . Ultrasound frequency-controlled microbubble dynamics in brain vessels regulate the enrichment of inflammatory pathways in the blood-brain barrier. Nat Commun. 2024; 15(1):8021. PMC: 11399249. DOI: 10.1038/s41467-024-52329-y. View

15.

Desgrosellier J, Cheresh D . Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2009; 10(1):9-22. PMC: 4383089. DOI: 10.1038/nrc2748. View

16.

Da Ros V, Oddo L, Toumia Y, Guida E, Minosse S, Strigari L . PVA-Microbubbles as a Radioembolization Platform: Formulation and the In Vitro Proof of Concept. Pharmaceutics. 2023; 15(1). PMC: 9862136. DOI: 10.3390/pharmaceutics15010217. View

17.

Sanai N, Polley M, McDermott M, Parsa A, Berger M . An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011; 115(1):3-8. DOI: 10.3171/2011.2.jns10998. View

18.

Domenici F, Brasili F, Oddo L, Cerroni B, Bedini A, Bordi F . Long-term physical evolution of an elastomeric ultrasound contrast microbubble. J Colloid Interface Sci. 2019; 540:185-196. DOI: 10.1016/j.jcis.2018.12.110. View

19.

Paradossi G, Oddo L, Cerroni B, Ben-Harush C, Ariel E, Di Meco F . In Vivo Toxicity Study of Engineered Lipid Microbubbles in Rodents. ACS Omega. 2019; 4(3):5526-5533. PMC: 6715268. DOI: 10.1021/acsomega.8b03161. View

20.

Sanai N, Berger M . Extent of resection influences outcomes for patients with gliomas. Rev Neurol (Paris). 2011; 167(10):648-54. DOI: 10.1016/j.neurol.2011.07.004. View